A carregar...

EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients

Background: Due to the insufficient understanding of the biological mechanisms, the improvement of therapeutic effects of prostate cancer (PCa) is limited. There is an urgent need to find the molecular mechanisms and underlying PCa to improve its early diagnosis, treatment, and prognosis.Methods: Th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yang Liao, Mingxin Wu, Yingjie Jia, Ruiyu Mou, Xiaojiang Li
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2022-04-01
Colecção:Frontiers in Cell and Developmental Biology
Assuntos:
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fcell.2022.843604/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!